NCT00087854View on ClinicalTrials.gov

Study of Individualized Amonafide to Treat Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Prostate Cancer
Interventions
DRUG

Amonafide L-malate (drug)

Trial Locations (8)

21231

Cancer Center at John Hopkins, Baltimore

44195

The Cleveland Clinic, Cleveland

63110

Barnard Cancer Center, St Louis

90033

USC Norris Comprehensive Cancer Center, Los Angeles

98109

Seattle Cancer Care Alliance, Seattle

08901

Cancer Institute of New Jersey, New Brunswick

10032-3789

Herbert Irving Cancer Center, New York

19111-2497

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
lead

Xanthus Pharmaceuticals, Inc.

INDUSTRY

NCT00087854 - Study of Individualized Amonafide to Treat Prostate Cancer | Biotech Hunter | Biotech Hunter